117 filings
Page 4 of 6
8-K
qup3eio5
21 Jun 21
Submission of Matters to a Vote of Security Holders
4:31pm
DEFA14A
4xi0fbsm r5qh05ct7op
14 May 21
Additional proxy soliciting materials
4:05pm
8-K
rnyrtawk3 rlno
12 May 21
Amwell® Announces Results for First Quarter 2021
4:10pm
DEFA14A
jpqdojf4jnchrx25aeq3
30 Apr 21
Additional proxy soliciting materials
4:09pm
DEF 14A
w24vll9
30 Apr 21
Definitive proxy
4:05pm
10-K
wmzzn7yy8
26 Mar 21
Annual report
4:02pm
8-K
70stv3m3ad5l5feu
24 Mar 21
Amwell® Announces Results for Fourth Quarter and Full Year 2020
4:16pm
424B4
aazbix9a8fv86o6
15 Jan 21
Prospectus supplement with pricing info
4:21pm
EFFECT
p6sri0q
15 Jan 21
Notice of effectiveness
12:15am
8-K
kfhp lsn6ko
12 Jan 21
Results of Operations and Financial Condition
4:41pm
CORRESP
lvle8rt40zonv59s95
12 Jan 21
Correspondence with SEC
12:00am
CORRESP
xygcj5
12 Jan 21
Correspondence with SEC
12:00am
UPLOAD
lqb68oyzg5
11 Jan 21
Letter from SEC
12:00am
DRS
pk8cbbf 5wi
6 Jan 21
Draft registration statement
12:00am
10-Q
ywxcj9vgo qh1e
13 Nov 20
Quarterly report
4:07pm
8-K
a8jwvmg
12 Nov 20
Amwell® Announces Results for Third Quarter 2020
4:28pm
8-K
ez92d6 ziq5j3f8b1z
9 Oct 20
Amwell Announces Appointment of Deborah C. Jackson to its Board of Directors
11:35am
8-K
wojfz0glma xu9tgi
22 Sep 20
Amwell Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
8:39am